about
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease3D quantitative imaging of unprocessed live tissue reveals epithelial defense against bacterial adhesion and subsequent traversal requires MyD88Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical studyComparison of diagnostic tests in distinct well-defined conditions related to dry eye disease.Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dyeSpontaneous bacterial keratitis in CD36 knockout mice.Optimizing evaluation of Lissamine Green parameters for ocular surface staining.The challenge of dry eye diagnosis.Vital dyes in ophthalmology: a chemical perspective.Documentation of corneal epithelial defects with fluorescein-enhanced digital fundus camera photography.Inhibition of Ultraviolet B-Induced Expression of the Proinflammatory Cytokines TNF-α and VEGF in the Cornea by Fucoxanthin Treatment in a Rat Model.Human corneal epithelial cell shedding and fluorescein staining in response to silicone hydrogel lenses and contact lens disinfecting solutions.The use of dye in ophthalmology.Drug delivery into the eye with the use of ultrasound.Ocular surface changes in thyroid eye disease.Ocular surface assessment in patients with obstructive sleep apnea-hypopnea syndrome.Precipitation of vital dyes with topical anaesthetics: a potential pitfall.Non-invasive assessment of porcine oocyte quality by supravital staining of cumulus-oocyte complexes with lissamine green B.Putting vital stains in context.Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis.
P2860
Q26746232-4CE81B07-D561-43C8-89EF-381C08476C64Q27322739-CEA5EC8B-8703-4FBC-A62A-9D11161DB9C7Q33280498-B832751E-B7EB-4DA7-8B41-61B823FC1426Q33645315-42072B7A-D7E7-4AF9-9856-DE43273AFA5EQ34313371-B0D5185F-3FE7-46AB-BD46-3AC63A1DD6F8Q34646627-C3947F90-0CFC-4F5E-9A64-5E6B8A809D4AQ35542678-81F7E7A4-9A1C-415E-B11C-4686AA1DE69EQ37233339-1B238237-2EDE-4EB6-A035-9665E03CD33DQ38176655-C5E0689F-6CAD-4E3B-9409-0E53526DA7F9Q39839760-C204634F-2A13-4B1F-B782-ED25C41105ACQ42112957-758AF28C-4BFC-427E-A3A1-8F8A3C8365A8Q44666122-61FD2DC5-E9C8-4552-8588-22A76E69465CQ44956412-A881EECC-D1D0-4D92-9A9F-9D615B47AFE2Q45078110-A572407F-9090-4CB9-B979-6AC85F874B93Q45989934-8E077C37-9041-4FB9-B9F5-F658DF7DD348Q48240182-24305C89-E5C9-4AFB-990E-277E1CD62DEAQ48470811-50519728-C717-4B14-BCA1-415D873B69C6Q48550741-5C7E6964-76B0-40FF-98AE-BD56D3493896Q50489431-E03047A2-1A59-4843-A2FD-2097C0F20F7AQ53689232-4BC262BC-CBBB-4F39-9946-C97458DC2724
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The use of vital dyes in corneal disease.
@ast
The use of vital dyes in corneal disease.
@en
The use of vital dyes in corneal disease.
@nl
type
label
The use of vital dyes in corneal disease.
@ast
The use of vital dyes in corneal disease.
@en
The use of vital dyes in corneal disease.
@nl
prefLabel
The use of vital dyes in corneal disease.
@ast
The use of vital dyes in corneal disease.
@en
The use of vital dyes in corneal disease.
@nl
P1476
The use of vital dyes in corneal disease.
@en
P2093
P304
P356
10.1097/00055735-200008000-00005
P577
2000-08-01T00:00:00Z